Research  >  Research  >  Labs & groups  >  Centre for Mobile Computing in Mental Health  >  Past projects  >  Identification of very early response to quetiapine augmentation in the treatment of major depressive disorder
Share:  
|
PAGE
MENU

Identification of very early response to quetiapine augmentation in the treatment of major depressive disorder

Identification of very early response to quetiapine augmentation in the treatment of major depressive disorder (2009 to 2012)

The Centre for Mobile Computing in Mental Health is using an augmented version of VADIS mental health telemetry software to track changes in symptoms of major depressive disorder following a pharmaceutical intervention.

Dr. Ayal Schaffer from Sunnybrook Research Institute is the principal investigator of this project.

Project funding is from Astra Zeneca.Project results are in press in Psychiatry Research.

This project was featured in the cover story of U of T Medicine Magazine's spring 2013 edition.